FDA Approved: EVEROLIMUS — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved Par Health USA, LLC's Original Application for EVEROLIMUS (a generic version of everolimus). The approval enables the generic product to be markete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Hr-positive
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma
• Subependymal Giant Cell Astrocytoma
• Tuberous Sclerosis Complex-associated Renal Angiomyolipoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

ORIG AP for EVEROLIMUS (EVEROLIMUS)